These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7986767)

  • 1. Sustained attention and positive formal thought disorder in schizophrenia.
    Pandurangi AK; Sax KW; Pelonero AL; Goldberg SC
    Schizophr Res; 1994 Sep; 13(2):109-16. PubMed ID: 7986767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auditory sustained attention in schizophrenia: a comparison of the Continuous Performance Test and the Pigache Attention Task.
    Pigache RM
    Psychiatry Res; 1996 Mar; 60(2-3):155-65. PubMed ID: 8723306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attentional dysfunctions in neuroleptic-naive and neuroleptic-withdrawn schizophrenic patients and their siblings.
    Finkelstein JR; Cannon TD; Gur RE; Gur RC; Moberg P
    J Abnorm Psychol; 1997 May; 106(2):203-12. PubMed ID: 9131840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Neuropsychological Correlates in Positive and Negative Formal Thought Disorder Syndromes: The Thought and Language Disorder Scale in Endogenous Psychoses.
    Nagels A; Fährmann P; Stratmann M; Ghazi S; Schales C; Frauenheim M; Turner L; Hornig T; Katzev M; Müller-Isberner R; Grosvald M; Krug A; Kircher T
    Neuropsychobiology; 2016; 73(3):139-47. PubMed ID: 27058747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention disorders in schizophrenia.
    Suwa H; Matsushima E; Ohta K; Mori K
    Psychiatry Clin Neurosci; 2004 Jun; 58(3):249-56. PubMed ID: 15149289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atypical neuroleptics on sustained attention deficits in schizophrenia: a trial of risperidone versus haloperidol.
    Liu SK; Chen WJ; Chang CJ; Lin HN
    Neuropsychopharmacology; 2000 Mar; 22(3):311-9. PubMed ID: 10693159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients.
    Chen WJ; Liu SK; Chang CJ; Lien YJ; Chang YH; Hwu HG
    Am J Psychiatry; 1998 Sep; 155(9):1214-20. PubMed ID: 9734545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimensions of attention impairment and negative symptoms in schizophrenia: a multidimensional approach using the conners continuous performance test in a Spanish population.
    Sanz JC; Gómez V; Vargas ML; Marín JJ
    Cogn Behav Neurol; 2012 Jun; 25(2):63-71. PubMed ID: 22543264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS).
    Nuechterlein KH; Green MF; Calkins ME; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Light GA; Radant AD; Seidman LJ; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Swerdlow NR; Tsuang DW; Tsuang MT; Turetsky BI; Braff DL
    Schizophr Res; 2015 Apr; 163(1-3):38-46. PubMed ID: 25749017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effectiveness of Conners' CPT and the CPT-identical pairs at distinguishing between smokers and nonsmokers with schizophrenia.
    Roth M; Hong LE; McMahon RP; Fuller RL
    Schizophr Res; 2013 Aug; 148(1-3):29-33. PubMed ID: 23791390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vigilance deficits in schizophrenics and affectively disturbed patients.
    Rund BR; Orbeck AL; Landrø NI
    Acta Psychiatr Scand; 1992 Sep; 86(3):207-12. PubMed ID: 1414414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls.
    Barr RS; Culhane MA; Jubelt LE; Mufti RS; Dyer MA; Weiss AP; Deckersbach T; Kelly JF; Freudenreich O; Goff DC; Evins AE
    Neuropsychopharmacology; 2008 Feb; 33(3):480-90. PubMed ID: 17443126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sustained attention/vigilance changes over time in schizophrenics and controls during a degraded stimulus Continuous Performance Test.
    Mass R; Wolf K; Wagner M; Haasen C
    Eur Arch Psychiatry Clin Neurosci; 2000; 250(1):24-30. PubMed ID: 10738861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vulnerability to schizophrenia. III: Importance and limits of the Identical Pairs Continuous Performance Test].
    Laurent A; Rochet T; D'Amato T; Anchisi AM; Daumal M; Favre P; Bougerol T; Dalery J
    Encephale; 2000; 26(2):48-55. PubMed ID: 10858916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention deficits assessed by Continuous Performance Test and Span of Apprehension Test in Japanese schizophrenic patients.
    Ito M; Kanno M; Mori Y; Niwa S
    Schizophr Res; 1997 Feb; 23(3):205-11. PubMed ID: 9075298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontal lobe tasks, antipsychotic medication, and schizophrenia syndromes.
    Himelhoch S; Taylor SF; Goldman RS; Tandon R
    Biol Psychiatry; 1996 Feb; 39(3):227-9. PubMed ID: 8837987
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of illness duration on perceptual asymmetry in schizophrenia.
    Carr V; Wale J; Dewis S; Stephan L
    Schizophr Res; 1992 Sep; 7(3):211-6. PubMed ID: 1356424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study.
    Lin AS; Chan HY; Peng YC; Chen WJ
    BMC Psychiatry; 2019 Jul; 19(1):220. PubMed ID: 31299940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attentional vulnerability indicators, thought disorder, and negative symptoms.
    Nuechterlein KH; Edell WS; Norris M; Dawson ME
    Schizophr Bull; 1986; 12(3):408-26. PubMed ID: 3764359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients.
    Sirivichayakul S; Kanchanatawan B; Thika S; Carvalho AF; Maes M
    Neurotox Res; 2019 Jan; 35(1):122-138. PubMed ID: 30056534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.